Journal of Cardiac Failure
Volume 14, Issue 6 , Pages 515-520 , August 2008

Outcomes of Volume-Overloaded Cardiovascular Patients Treated With Ultrafiltration

  • Brian E. Jaski, MD

      Affiliations

    • San Diego Cardiac Center, Sharp Memorial Hospital, San Diego, California
    • Corresponding Author InformationReprint requests: Brian E. Jaski, MD, San Diego Cardiac Center, 3131 Berger Avenue, San Diego, CA 92123.
  • ,
  • Andrew Romeo, BS

      Affiliations

    • Sharp Memorial Hospital, San Diego, California
  • ,
  • Bryan Ortiz

      Affiliations

    • Sharp Memorial Hospital, San Diego, California
  • ,
  • Peter M. Hoagland, MD

      Affiliations

    • San Diego Cardiac Center, Sharp Memorial Hospital, San Diego, California
  • ,
  • Maureen Stone, RN

      Affiliations

    • Sharp Memorial Hospital, San Diego, California
  • ,
  • Dale Glaser, PhD

      Affiliations

    • Sharp Memorial Hospital, San Diego, California
  • ,
  • Lorie Thomas, MSN

      Affiliations

    • Sharp Memorial Hospital, San Diego, California
  • ,
  • Cynthia Walsh, MSN

      Affiliations

    • Sharp Memorial Hospital, San Diego, California
  • ,
  • Sidney C. Smith Jr., MD

      Affiliations

    • University of North Carolina, Chapel Hill, North Carolina

Received 27 July 2007 ,Revised 1 February 2008 ,Accepted 5 February 2008.

References 

  1. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007–2018
  2. Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541–1547
  3. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. N Engl J Med. 1974;291:747–751
  4. Jaski B, Ha J, Denys B, Lamba S, Trupp R, Abraham W. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail. 2003;9:227–231
  5. Liang KV, Hiniker AR, Williams AW, Karon BL, Greene EL, Redfield MM. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail. 2006;12:707–714
  6. Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (Rapid-CHF) trial. J Am Coll Cardiol. 2005;46:2043–2046
  7. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, et al. UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675–683
  8. Fonarow G, Adams K, Abraham W, Yancy C, Boscardin W, ADHERE Scientific Advisory Committee, Study Group, and Investigators . Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572–580
  9. Jaski B, Miller D. Ultrafiltration in decompensated heart failure. Curr Heart Fail Rep. 2005;2:148–154
  10. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  11. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209–216
  12. Joint Commission on Accreditation of Healthcare Organizations. Available at: http://www.jointcommission.orgAccessed June 1, 2007
  13. Fonarow GC. ADHERE Scientific Advisory Committee, The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med. 2003;4(Suppl 7):S21–S30
  14. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure. JAMA. 2003;290:2581–2587
  15. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaren JR, Wynne J. ADHERE Scientific Advisory Committee and Investigators. Prevalence of renal dysfunction and its impact on outcome of patients. J Card Fail. 2007;13:422–430
  16. Rudiger A, Harjola VP, Muller A, Mattila E, Saila P, Nieminen M, et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail. 2005;7:662–670
  17. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. for the OPTIMIZE-HF Investigators and Coordinators Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217–2226

 The study was supported in part by the Rosa Azus Cardiovascular Fund of the Sharp Healthcare Foundation, San Diego, California.

PII: S1071-9164(08)00064-X

doi: 10.1016/j.cardfail.2008.02.003

Journal of Cardiac Failure
Volume 14, Issue 6 , Pages 515-520 , August 2008